You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / SOLARA ACTIVE PHARMA SCIENCE

SOLARA ACTIVE PHARMA SCIENCE
Intrinsic Value | Fundamental Analysis

Returns | 1W : 3.6% , 1M : 23.4%,1Y : 266.6%
BOM : 541540     NSE : SOLARA    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Upward
Pledged Shares : None or < 25%
May 18,2021
Price(EOD): Rs. 1,756.60
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
MarketCap: Rs. 6,306.19 Cr
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
SOLARA ACTIVE PHARMA SCIENCE 3.6% 23.4% 266.6%
SUN PHARMACEUTICAL INDUSTRIES -2.4% 9.2% 50.7%
DR REDDYS LABORATORIES -1.5% 7.7% 40.7%
DIVIS LABORATORIES -1.9% 5.7% 70.9%
CIPLA -0.7% -3.3% 54.7%
BIOCON -0.7% -4.8% 15%
AUROBINDO PHARMA -2.5% 9.9% 50.5%
LUPIN -0.9% 13.1% 37.8%
TORRENT PHARMACEUTICALS 0.3% 6.1% 14.8%


FUNDAMENTAL ANALYSIS OF SOLARA ACTIVE PHARMA SCIENCE

 
Fundamentals Score
[Last Annual Data : Mar2020 | TTM
Trailing Twelve Months (TTM) is calculated using last 4 quarterly data and is a good substitute to track Annual results.
Learn More
]
Show Me the Stocks with Fundamentals better than SOLARA ACTIVE PHARMA SCIENCE Premium


VALUATION OF SOLARA ACTIVE PHARMA SCIENCE

 
Valuation Score
Ratio Standalone
P/E
P/B
P/S
41.92
P/E Calculated based on EPS of 41.9
[ Mar2020 - Standalone Results ]

4.76
P/B Calculated based on Book Value of 368.74
[ Mar2020 - Standalone Results ]

4.71
P/S Calculated based on Revenues of 1339.23 Cr
[ TTM - Standalone Results ]

Show Me the Stocks with Valuation better than SOLARA ACTIVE PHARMA SCIENCE Premium


FAIR VALUE OF SOLARA ACTIVE PHARMA SCIENCE

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
487%
687%
464%

SHARE PRICE MOMENTUM OF SOLARA ACTIVE PHARMA SCIENCE

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2020
2019
2018
Avg_3yrs
0.71
0.63
0.82
0.72
0.72
0.63
0.83
0.73
[Last Annual Data : Mar2020]

PLEDGED SHARES

Pledged Shares
16.42 %
As on : Mar2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
4.11%
-5.4%
-13.12%
-13.12%
49.68%
97.91%
214.36%
214.36%
QtrlyTrend
2
Latest Qtr: Mar2021

SOLARA ACTIVE PHARMA SCIENCE related INDICES

BSE Indices1W1M1Y
S&P BSE 500 1.6% 4.9% 69.2%
S&P BSE ALLCAP 1.5% 5.2% 70.6%
S&P BSE MIDSMALLCAP 1.2% 8.3% 96.1%
S&P BSE 400 MIDSMALLCAP 1.1% 7.9% 96.3%
S&P BSE 250 SMALLCAP 1.1% 10.1% 116.7%
S&P BSE SMALL CAP 1.1% 9.9% 110.7%
S&P BSE HEALTHCARE -1.6% 6.9% 59.5%
NSE Indices1W1M1Y
NIFTY 500 1.6% 4.9% 68.6%
NIFTY MID SMALL400 1.1% 8% 97.4%
NIFTY SMALLCAP250 0.9% 10.8% 120.3%

FAQ [Frequently Asked Questions]


Is SOLARA good for long term investment?

As on 18-May-2021, the Fundamentals of SOLARA are Average and hence you can wait for the results to improve to invest for long term ! See Financial Performance of SOLARA ACTIVE PHARMA SCIENCE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is SOLARA UnderValued or OverValued?

As on 18-May-2021, SOLARA is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of SOLARA ?

As on 18-May-2021, the Intrinsic Value of SOLARA is Rs. 299.46 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 299.46
Fair Value [Median EV / Sales Model] : Rs. 223.14
Fair Value [Median Price / Sales Model] : Rs. 311.49
Median Fair Value of SOLARA : Rs. 299.46

Is SOLARA trading at a Premium or Discount?

As on 18-May-2021, SOLARA is trading at a Premium of 487% based on the Median Intrinsic Value!

Is it right time to buy SOLARA shares?

As on 18-May-2021, SOLARA is Over Valued and hence NOT a good buying opportunity according to Share Valuation at this time!

What is the Financial Performance of Industry Peers of SOLARA?

Check out Financials of Industry Peers using below links:
Financials of SUN PHARMACEUTICAL INDUSTRIES LTD
Financials of DR REDDYS LABORATORIES LTD
Financials of DIVIS LABORATORIES LTD
Financials of CIPLA LTD
Financials of BIOCON LTD
Financials of AUROBINDO PHARMA LTD
Financials of LUPIN LTD
Financials of TORRENT PHARMACEUTICALS LTD
Financials of CADILA HEALTHCARE LTD
Financials of ABBOTT INDIA LTD

What are the Frequent Comparisons with SOLARA?

SOLARA ACTIVE PHARMA SCIENCE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DR REDDYS LABORATORIES LTD
SOLARA ACTIVE PHARMA SCIENCE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD
SOLARA ACTIVE PHARMA SCIENCE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD
SOLARA ACTIVE PHARMA SCIENCE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs BIOCON LTD
SOLARA ACTIVE PHARMA SCIENCE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs AUROBINDO PHARMA LTD
SOLARA ACTIVE PHARMA SCIENCE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs LUPIN LTD
SOLARA ACTIVE PHARMA SCIENCE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs TORRENT PHARMACEUTICALS LTD
SOLARA ACTIVE PHARMA SCIENCE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs CADILA HEALTHCARE LTD
SOLARA ACTIVE PHARMA SCIENCE LTD vs SUN PHARMACEUTICAL INDUSTRIES LTD vs ABBOTT INDIA LTD

Open Demat Account & Start Investing
    Affiliate Links

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z